X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,975 | -41.7% | 61,445 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $114,966 | +41.9% | 59,261 | +532.5% | 0.00% | – |
| Q1 2021 | $81,000 | +35.0% | 9,370 | +0.3% | 0.00% | – |
| Q4 2020 | $60,000 | -7.7% | 9,346 | -2.8% | 0.00% | – |
| Q3 2020 | $65,000 | -29.3% | 9,614 | -2.2% | 0.00% | – |
| Q2 2020 | $92,000 | +1.1% | 9,832 | +7.7% | 0.00% | – |
| Q1 2020 | $91,000 | +13.8% | 9,131 | +22.9% | 0.00% | – |
| Q4 2019 | $80,000 | -15.8% | 7,431 | -0.9% | 0.00% | – |
| Q3 2019 | $95,000 | +41.8% | 7,495 | +68.8% | 0.00% | – |
| Q2 2019 | $67,000 | +570.0% | 4,439 | +705.6% | 0.00% | – |
| Q1 2019 | $10,000 | – | 551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |